- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on AIDS-Related Hodgkin Lymphoma
Total 5754 results
-
Peking Union Medical College HospitalCellular Biomedicine Group Ltd.CompletedB-cell Non-Hodgkin LymphomaChina
-
Menarini GroupTerminatedMetastatic Solid Tumors | Relapsed/Refractory Non-Hodgkin LymphomaItaly, Spain, Belgium, United Kingdom
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.RecruitingStudy of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's LymphomaCD20-positive B-cell Non-Hodgkin's LymphomaChina
-
Shanghai Pharmaceuticals Holding Co., LtdCompletedCD20 Positive B Cell Non-Hodgkin's LymphomaChina
-
Robert LowskyNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Hodgkin Lymphoma | Chronic Lymphocytic Leukemia | Myelodysplastic Syndrome | B-Cell Non-Hodgkin Lymphoma | Myeloproliferative Neoplasm | T-Cell Non-Hodgkin LymphomaUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingHodgkin's Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL)Canada, United States, Brazil, Czechia, France, Italy, Poland, Russian Federation, South Africa, Turkey, Ukraine
-
Second Affiliated Hospital, School of Medicine,...RecruitingB-cell Non Hodgkin LymphomaChina
-
AbClonRecruitingB-cell Non Hodgkin LymphomaKorea, Republic of
-
University of ChicagoActive, not recruitingCLL | B-cell Non Hodgkin LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; University of Washington; H. Lee...Active, not recruiting
-
UWELL BiopharmaTri-Service General HospitalUnknownB-cell Non-Hodgkin LymphomaTaiwan
-
Tessa TherapeuticsBristol-Myers SquibbActive, not recruitingClassical Hodgkin Lymphoma | Hodgkin Disease Recurrent | Hodgkin Disease RefractoryUnited States
-
Eden BioCell Ltd.National Taiwan University HospitalTerminatedFollicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-cell Acute Lymphoblastic Leukemia | High-grade B-cell Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma RefractoryTaiwan
-
University of Michigan Rogel Cancer CenterCompletedLymphoma, Non-Hodgkin | Hodgkin's LymphomaUnited States
-
BeiGeneRecruitingRefractory Chronic Lymphocytic Leukemia | Refractory Non-Hodgkin Lymphoma | Relapsed Follicular Lymphoma | Refractory Small Lymphocytic Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Refractory Diffuse Large B-cell Lymphoma | Transformed Non-Hodgkin Lymphoma | Relapsed... and other conditionsChina, Australia
-
University of CologneCompletedNodular Lymphocyte-Predominant Hodgkin's LymphomaGermany
-
Stanford UniversityMerck Sharp & Dohme LLCRecruitingHodgkin Lymphoma | Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma | Relapsed Classical Hodgkin LymphomaUnited States
-
Cellectis S.A.RecruitingB-cell Non-Hodgkin Lymphoma (B-NHL)United States, Spain, France
-
University of CologneNovartisTerminated
-
Masonic Cancer Center, University of MinnesotaCompletedDiffuse Large B Cell Non-Hodgkin LymphomaUnited States
-
Columbia UniversityTerminatedHodgkin Disease | Lymphoma, Non-hodgkinUnited States
-
National Cancer Institute (NCI)CompletedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | CD20 PositiveUnited States
-
AbbVieInfinity Pharmaceuticals, Inc.WithdrawnChronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Small Lymphocytic LymphomaUnited States
-
Peking Union Medical College HospitalPeking University First Hospital; Chinese PLA General Hospital; Peking University... and other collaboratorsRecruitingT Cell Non-Hodgkin's LymphomaChina
-
University of WashingtonGenentech, Inc.RecruitingMarginal Zone Lymphoma | Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Indolent B-Cell Non-Hodgkin Lymphoma | Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Refractory Extranodal Marginal Zone...United States
-
National Cancer Institute (NCI)TerminatedRecurrent Cutaneous T-cell Non-Hodgkin Lymphoma | Stage I Cutaneous T-cell Non-Hodgkin Lymphoma | Stage II Cutaneous T-cell Non-Hodgkin LymphomaUnited States
-
Genor Biopharma Co., Ltd.RecruitingB-cell Non-Hodgkin's LymphomaChina
-
AmgenCompletedLymphoma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Diffuse Large Cell Lymphoma | Low Grade Lymphoma
-
Incyte CorporationTerminatedRefractory Hodgkin Lymphoma | Recurrent Adult Hodgkin's Lymphoma
-
Tel-Aviv Sourasky Medical CenterUnknownLymphoma | Follicular Lymphoma | Non Hodgkin Lymphoma
-
British Columbia Cancer AgencyHoffmann-La RocheActive, not recruitingLymphoma, Non-Hodgkin | Advanced Stage Diffuse Large B-Cell Non-Hodgkin's LymphomaCanada
-
Bristol-Myers SquibbCompletedCancer - Solid Tumors and B-Cell Non-Hodgkin's LymphomaUnited States, France, Spain, Germany
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | B-cell Non-Hodgkin's LymphomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Lymphoproliferative Disorder | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Grade 3 Follicular... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Celgene CorporationCompletedRefractory/Relapsed Indolent Non-Hodgkin LymphomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedFollicular Lymphoma | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | B-Cell Non-Hodgkin Lymphoma | Adult Diffuse Large B-Cell Lymphoma | T-Cell Non-Hodgkin LymphomaUnited States
-
Shanghai Unicar-Therapy Bio-medicine Technology...RecruitingRelapsed or Refractory Non-Hodgkin's LymphomaChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphomaUnited States, Canada
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Genentech, Inc.; Pharmacyclics LLC.RecruitingNon-Hodgkin's Lymphoma | Indolent Non-hodgkin Lymphoma | Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Ann Arbor Stage II Follicular Lymphoma | Ann Arbor Stage II Nodal Marginal Zone Lymphoma | Ann Abor Stage III B-Cell Non-Hodgkin Lymphoma | Ann Arbor... and other conditionsUnited States
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B-cells Non-Hodgkin LymphomaItaly
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedCD20-positive B-cell Non-Hodgkin LymphomaUnited States, France
-
University of CologneCompletedLymphocyte Predominant Hodgkin´s Lymphoma (LPHD)Germany
-
Case Comprehensive Cancer CenterActive, not recruitingNon-hodgkin LymphomaUnited States
-
Benjamin TomlinsonActive, not recruitingNon-Hodgkin LymphomaUnited States
-
New York Medical CollegeCompletedNon Hodgkin Lymphoma
-
AstraZenecaTerminatedNon-Hodgkin LymphomaSpain, United States, Korea, Republic of, France, Portugal, Australia, Italy
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
Tahir LatifActive, not recruitingNon Hodgkin LymphomaUnited States
-
Spectrum Pharmaceuticals, IncThe Leukemia and Lymphoma SocietyTerminated
-
ImmunityBio, Inc.Withdrawn